Correction of Sub-clinical Prolongation of COAGulation Tests and/or Low Platelets before TRACHeotomy - Randomized controlled trial *

Correction of Sub-clinical Prolongation of COAGulation Tests and/or Low Platelets before TRACHeotomy - Randomized controlled trial * - The COAG-TRACH study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON29953

Enrollment

152

Registered

2006-07-12

Start date

2006-07-01

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

clinical significant blood loss complications

Interventions

In group 1 patients receive platelets and/or plasma before PDT until normal values are reached. In group 2 patients do not receive platelets and/or plasma.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: sub-clinical lengthening of coagulation tests and or low platelets use of Ascal planned PDT age > 18 years Informed consent

Exclusion criteria

Exclusion criteria: contraindication for PDT (i.e., surgical tracheotomy is preferred) contra-indications for transfusion of blood products contra-indication for correction of coagulation disorders PTT > 20 seconds use of clopidogrel

Design outcomes

Primary

Measure	Time frame
the volume of blood loss during PDT the intensity of intra-tracheal bleeding time until no blood is visible in tracheal aspirates	—

Secondary

Measure	Time frame
The amount of bloodproducts used during and after tracheotomy	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)